Case Report
Published on 03 Jun 2024
Omalizumab in combination with subcutaneous immunotherapy for the treatment of multiple allergies associated with attention-deficit/hyperactivity disorder: a case report and a literature review
in Obstetric and Pediatric Pharmacology
- 2,475 views
- 2 citations